Overview

Comparison of Skin Thickness Under Treatment With Pimecrolimus 1% Cream, Hydrocortisonacetat 1% Cream, Betamethasonvalerat 0,1% Cream and Clobetasol-17-propionat 0,05% Cream Assessed by Optical Coherence Tomography (OCT) and 20-MHZ Ultrasound

Status:
Completed

Trial end date:
2008-10-01

Target enrollment:

Participant gender:

Summary

to compare the atrophogenic potentials of pimecrolimus 1% cream, hydrocortisonacetat 1% cream, betamethasonvalerat 0,1% cream and clobetasol-17-Propionat 0,05% cream

Phase:

Phase 1

Details

Lead Sponsor:

Technische Universität Dresden

Treatments:

Clobetasol
Pimecrolimus
Tacrolimus